Publications
5891 Results
- Journal / Conference
- Seminars in Oncology 35(5):545-552
- Year
- 2008
- Research Committee(s)
- Breast, Cancer Control, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lung, Lymphoma, Melanoma, Myeloma, Prevention, Screening, and Surveillance, and Sarcoma
- Study Number(s)
- S0000, S0003, S0033, SWOG-7436, SWOG-7808, SWOG-7827, SWOG-8006, SWOG-8216/38, SWOG-8378, SWOG-8412, SWOG-8494 (INT-0036), SWOG-8501 (INT-0051), SWOG-8507, SWOG-8516 (INT-0067), SWOG-8591(NCI Intergroup #0035), SWOG-8593 (INT-0065), SWOG-8600, SWOG-8642, SWOG-8691 (INT-0073), SWOG-8692 (INT-0075), SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8736 (INT-0093), SWOG-8794, SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12), SWOG-8809, SWOG-8812, SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817), SWOG-8894 (INT-0105) (EST-2889), SWOG-8897, SWOG-8949, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9126, SWOG-9133, SWOG-9210, SWOG-9217, SWOG-9308, SWOG-9509, S9916
The Southwest Oncology Group: progress in cancer research [PMID18929152]
- Journal / Conference
- Current Oncology Reports 10(6):529-532
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID: 18928669
- Study Number(s)
- SWOG-9217
Prostate cancer chemorevention update of the prostate cancer prevention trial findings and implications for clinical practice
- Journal / Conference
- Urologic Oncology 26(2):125-132
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18312929
- Study Number(s)
- SWOG-9217
Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic medical center
- Journal / Conference
- Journal of Clinical Oncology 26(33):5360-5357
- Year
- 2008
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Correlation of kinase genotype and clinical outcome in the North American Intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by Cancer and Leukemia Group B and Southwest Oncology Group [PMC2651078; PMID18955451]
- Journal / Conference
- Journal of Clinical Oncology 26(35):5748-5754
- Year
- 2008
- Research Committee(s)
- Melanoma
- Study Number(s)
- E3695
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, decarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and decarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group [PMC2645104; PMID 19001327]
- Journal / Conference
- Blood 112:abst.#2715
- Year
- 2008
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Analytical approaches for the BOAC SNP panel association with progression free survival in myeloma
- Journal / Conference
- Journal of Clinical Oncology 26(15s):abst. #8080
- Year
- 2008
- Research Committee(s)
- Lung
- Study Number(s)
- N0426
A phase II second-line study of pemetrexed (pem) in combination with bevacizumab (bev) in patients with advanced non-small cell lung cancer (NSCLC): an NCCTG and SWOG study
- Journal / Conference
- Journal of Clinical Oncology 26(15s):abstr. #18034
- Year
- 2008
- Research Committee(s)
- Leukemia
- Study Number(s)
- C10403
Older adolescents and young adults with acute lymphoblastic leukemia (ALL) in the United States: from the lowest to highest death rate and number of deaths -- more rationale for the CALBG-WSOG-ECOG C10403 trial based on COG AALL0232
- Journal / Conference
- Gynecologic Oncology 108(3) Suppl. 1:S3
- Year
- 2008
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0013